Medical Communications

German drug major Merck along with Pfizer has joined forces with Verastem to develop the trial drug candidate avelumab to …

Sanofi Genzyme, the branch of the French-based pharma company that focuses on diseases difficult to diagnose and treat, have published …

New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …

Belgian drug company UCB says it is looking at a regulatory filing for its trial drug romosozumab to treat osteoporosis …

In an already troubled week for Valeant Pharmaceuticals, the company has now announced that its group chairman and executive vice …

Industry veteran Bill Griffiths has joined NDA Group to head up the company’s UK consulting team and NDA’s advisory board.  …

LEO Pharma has appointed Michael Hinchy as dermatology director with responsibility for its UK/Ireland affiliate. Michael brings over 16 years …

Swiss fertility treatment company Ferring Pharmaceuticals on Tuesday named Aaron Graff the chief executive of its US unit, Ferring Holding. …

Medical education specialist, Wave, has made five new appointments, which the company says reflects the growth in its business over …

UCB Pharma’s Briviact (brivaracetam) has been authorised as an add-on treatment for partial onset seizures (POS), with or without secondary …

On Rare Disease Day 2016, UK charity Findacure says existing drugs may hold the key to new treatments and repurposing …

Boehringer Ingelheim has launched a collaborative initiative aimed at raising awareness and understanding of the rare lung disease Idiopathic Pulmonary …

Greg Rossi, head of the Oncology Business Unit, AstraZeneca UK and Ireland, and the company’s market access team, spoke to …

Werner Baumann will become the new chief executive of Bayer AG from May 1, the company has announced. The decision …

A year after Barack Obama announced the $200 million Precision Medicines Initiative (PMI), the US President yesterday outlined the next …